The clinical import of a retinal cholesterol embolus: it is a question of symptoms

References

• Mitchell P, Wang JJ, Weining L, et al. Prevalence of asymptomatic retinal emboli in an Australian urban community. Stroke. 1997;28:63–66.
   Web of Science ®Google Scholar
• Klein R, Klein BEK, Jensen SC, et al. Retinal emboli and stroke: the Beaver Dam eye study. Arch Ophthalmol. 1999;117:1063–1068.
   Google Scholar
• Klein R, Klein BEK, Moss SE, Meuer SM. Retinal emboli and cardiovascular disease: the Beaver Dam eye study. Trans Am Ophthalmol Soc. 2003;100:173–182.
   Google Scholar
• Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of retinal emboli in an older population. Stroke. 2006;37:908–910.
   Web of Science ®Google Scholar
• Hollenhorst RW Significance of bright plaques in the retinal arterioles. JAMA. 1961;178:23–29.
   PubMed Web of Science ®Google Scholar
• Coutu R. Treatment and management of the Hollenhorst plaque. Clin Eye Vis Care. 1993;5:52–58.
   Google Scholar
• Cross SS. How common is cholesterol embolism? J Clin Pathol. 1991;44:859–861.
   Web of Science ®Google Scholar
• Pfaffenbach DD, Hollenhorst RW. Morbidity and survivorship of patients with embolic cholesterol crystals in the ocular fundus. Am J Ophthalmol. 1973;75:66–72.
   Web of Science ®Google Scholar
• Bruno A, Jones WL, Austin JK, et al. Vascular outcomes in men with asymptomatic retinal cholesterol emboli: a cohort study. Ann Intern Med. 1995;122:249–253.
   Web of Science ®Google Scholar
• Wang JJ, Cugati S, Knudtson MD, et al. Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations. Stroke. 2006;37:1833–1836.
   PubMed Web of Science ®Google Scholar
• Hoki SL, Varma R, Lai MY, et al. Prevalence and associations of asymptomatic retinal emboli in Latinos: the Los Angeles Latino eye study. Am J Ophthalmol. 2008;145:143–148.
   Web of Science ®Google Scholar
• Mitchell P, Wang JJ, Smith W. Risk factors and significance of finding asymptomatic retinal emboli. Clin Experiment Ophthalmol. 2000;28:13–17.
   Web of Science ®Google Scholar
• Biousse V Cerebrovascular disease. In: Miller NR, Newman NJ, Biousse V, Kerrison JB, editors. Walsh and Hoyt's Clinical Neuro-Ophthalmology, 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2004;2.
   Google Scholar
• O’Donnell BA, Mitchell P. The clinical features and associations of retinal emboli. Aust N Z J Ophthalmol. 1992;20:11–17.
   Google Scholar
• Bruno A, Russell PW, Jones WL, et al. Concomitants of asymptomatic retinal cholesterol emboli. Stroke. 1992;23:900–902.
   Web of Science ®Google Scholar
• Ahmed R, Khetpal V, Merin LM, Chomsky AS. Case series: retrospective review of incidental retinal emboli found on diabetic retinopathy screening: is there a benefit to referral for work-up and management? Clin Diabetes. 2008;26:179–182.
   PubMedGoogle Scholar
• Bunt TJ. The clinical significance of the asymptomatic Hollenhorst plaque. J Vasc Surg. 1986;4:559–562.
   Web of Science ®Google Scholar
• Schwarcz TH, Eton D, Ellenby MI, et al. Hollenhorst plaques: retinal manifestations and the role of carotid endarterectomy. J Vasc Surg. 1990;11:635–641.
   Web of Science ®Google Scholar
• Wakefield MC, O’Donnell SD, Goff JM Jr. Re-evaluation of carotid duplex for visual complaints: who really needs to be studied? Ann Vasc Surg. 2003;17:635–640.
   Web of Science ®Google Scholar
• McCullough HK, Reinder CG, Hynan LS, et al. Ocular findings as predictors of carotid artery occlusive disease: is carotid imaging justified? J Vasc Surg. 2004;40:279–286.
   Google Scholar
• Dunlap AB, Kosmorsky GS, Kashyap VS. The fate of patients with retinal artery occlusion and Hollenhorst plaque. J Vasc Surg. 2007;46:1125–1129.
   Web of Science ®Google Scholar
• Sharma S, Brown GC, Pater JL, Cruess AF. Does a visible retinal embolus increase the likelihood of hemodynamically significant carotid artery stenosis in patients with acute retinal artery occlusion? Arch Ophthalmol. 1998;116:1602–1606.
   Google Scholar
• Sandercock PAG, Kavvadia E. The carotid bruit. Pract Neurol. 2002;2:221–224.
   Google Scholar
• Pickett CA, Jackson JL, Hemann BA, Atwood JE. Carotid bruit and cerebrovascular disease risk: a meta-analysis. Stroke. 2010;41:2295–2302.
   Web of Science ®Google Scholar
• Davies KN, Humphrey PRD. Do carotid bruits predict disease of the internal carotid arteries? Postgrad Med J. 1994;70:433–435.
   PubMed Web of Science ®Google Scholar
• Sauve JS, Thorpe KE, Sackett DL, et al. Can bruits distinguish high-grade from moderate symptomatic carotid stenosis? The North American symptomatic carotid endarterectomy trial. Ann Intern Med. 1994;120:633–637.
   PubMed Web of Science ®Google Scholar
• North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453.
   PubMed Web of Science ®Google Scholar
• Wolintz RJ. Carotid endarterectomy for ophthalmic manifestations: is it ever indicated? J Neuroophthalmol. 2005;25:259–261.
   Web of Science ®Google Scholar
• British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. BMJ. 2000;320:705–708.
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150:396–404.
   PubMed Web of Science ®Google Scholar
• Campbell CL, Smyth S, Montalescot G, Steinhubl SR. Aspirin dose for the prevention of cardiovascular disease: a systematic review. JAMA. 2007;297:2018–2224.
   PubMed Web of Science ®Google Scholar